Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Mallinckrodt, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013351
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imaging, nuclear imaging and contrast media and devices. Its generic products include addiction treatment products, compounding powders, unit dose products, and resource tool kit, among others. Mallinckrodt’s specialty brands and generics segments commercializes in the areas of neurology, nephrology, rheumatology, ophthalmology, pulmonology, rare disease products, and others. The company offers treatment to health conditions including pain, central nervous system disorders, autoimmune and rare diseases. The company has its presence in the US, the UK and Ireland. Mallinckrodt is headquartered in St. Louis, Missouri, the US.

Mallinckrodt, LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt, LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt, LLC, Medical Devices Deals, 2011 to YTD 2017 9
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Mallinckrodt Completes Acquisition Of Rights To Roxicodone From Xanodyne Pharma 11
Venture Financing 12
CNS Therapeutics Secures An Additional US$0.05 Million In Venture Financing 12
Partnerships 13
Mallinckrodt Enters Into Co-Promotion Agreement With Horizon Pharma For Duexis 13
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 15
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 16
Licensing Agreements 17
Intellipharmaceutics International Enters into Licensing Agreement with Mallinckrodt 17
Acquisition 18
Mallinckrodt Completes Acquisition Of CNS Therapeutics For US$100 Million 18
Mallinckrodt, LLC – Key Competitors 20
Mallinckrodt, LLC – Key Employees 21
Mallinckrodt, LLC – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Key Facts 2
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Mallinckrodt, LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Mallinckrodt, LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Mallinckrodt, LLC, Medical Devices Deals, 2011 to YTD 2017 9
Mallinckrodt, LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mallinckrodt Completes Acquisition Of Rights To Roxicodone From Xanodyne Pharma 11
CNS Therapeutics Secures An Additional US$0.05 Million In Venture Financing 12
Mallinckrodt Enters Into Co-Promotion Agreement With Horizon Pharma For Duexis 13
Zogenix Enters Into Co-Promotion Agreement With Mallinckrodt For Sumavel DosePro 15
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 16
Intellipharmaceutics International Enters into Licensing Agreement with Mallinckrodt 17
Mallinckrodt Completes Acquisition Of CNS Therapeutics For US$100 Million 18
Mallinckrodt, LLC, Key Competitors 20
Mallinckrodt, LLC, Key Employees 21
Mallinckrodt, LLC, Subsidiaries 22

★海外企業調査レポート[Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pfenex Inc (PFNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • Virgin Group Ltd.:企業の戦略・SWOT・財務分析
    Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Burlington Northern Santa Fe, LLC:企業の戦略・SWOT・財務分析
    Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report Summary Burlington Northern Santa Fe, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • McDermott International, Inc.:企業の戦略・SWOT・財務情報
    McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report Summary McDermott International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kinnov Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors …
  • Protalix BioTherapeutics Inc (PLX):企業の財務・戦略的SWOT分析
    Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • PV Crystalox Solar plc (PVCS):企業の財務・戦略的SWOT分析
    PV Crystalox Solar plc (PVCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • NRW Holdings Ltd:企業の戦略・SWOT・財務情報
    NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Helix Energy Solutions Group, Inc.:企業の戦略・SWOT・財務分析
    Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Latvijas Gaze (GZE1R):企業の財務・戦略的SWOT分析
    Latvijas Gaze (GZE1R) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Otrum AS:企業の戦略的SWOT分析
    Otrum AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Electricity Generating Public Co Ltd (EGCO):電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Iberdrola, S.A.:企業の戦略・SWOT・財務分析
    Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report Summary Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EQT Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EQT Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EQT Corp (EQT) is an integrated oil and gas company. It operates production fields in Marcellus, Upper Devonian, Ohio Utica and other plays in Appalachian Basin. The company produces and markets natural gas …
  • Main Street America Insurance Company:企業の戦略的SWOT分析
    Main Street America Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Telekom Austria AG (TKA):企業の財務・戦略的SWOT分析
    Telekom Austria AG (TKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Patterson Companies, Inc.
    Patterson Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Patterson Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Aprecia Pharmaceuticals Company-製薬・医療分野:企業M&A・提携分析
    Summary Aprecia Pharmaceuticals Company (Aprecia) is a healthcare products provider that develops and markets various therapeutic products. The company's zipdos technology platform is used in the production of sponge-like wafer forms of existing medicines. It also offers 3D printing technology platf …
  • Canada Energy Partners Inc (CE):企業の財務・戦略的SWOT分析
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. Canada Energy develops a wellbore mining …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆